- Home
- ADVM vs GCTS Comparison
ADVM vs GCTS Comparison
Compare ADVM & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- GCTS
- Stock Information
- Founded
- ADVM 2006
- GCTS 1998
- Country
- ADVM United States
- GCTS United States
- Employees
- ADVM N/A
- GCTS N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- GCTS Blank Checks
- Sector
- ADVM Health Care
- GCTS Finance
- Exchange
- ADVM Nasdaq
- GCTS Nasdaq
- Market Cap
- ADVM 94.6M
- GCTS 82.1M
- IPO Year
- ADVM 2014
- GCTS N/A
- Fundamental
- Price
- ADVM $4.31
- GCTS $1.40
- Analyst Decision
- ADVM Buy
- GCTS Strong Buy
- Analyst Count
- ADVM 5
- GCTS 1
- Target Price
- ADVM $16.60
- GCTS $5.00
- AVG Volume (30 Days)
- ADVM 1.0M
- GCTS 368.5K
- Earning Date
- ADVM 11-07-2025
- GCTS 11-12-2025
- Dividend Yield
- ADVM N/A
- GCTS N/A
- EPS Growth
- ADVM N/A
- GCTS N/A
- EPS
- ADVM N/A
- GCTS N/A
- Revenue
- ADVM $1,000,000.00
- GCTS $6,073,000.00
- Revenue This Year
- ADVM $1,191.10
- GCTS N/A
- Revenue Next Year
- ADVM N/A
- GCTS $1,597.96
- P/E Ratio
- ADVM N/A
- GCTS N/A
- Revenue Growth
- ADVM N/A
- GCTS N/A
- 52 Week Low
- ADVM $1.78
- GCTS $0.90
- 52 Week High
- ADVM $8.18
- GCTS $2.86
- Technical
- Relative Strength Index (RSI)
- ADVM 50.55
- GCTS 46.10
- Support Level
- ADVM $4.18
- GCTS $1.31
- Resistance Level
- ADVM $4.37
- GCTS $1.75
- Average True Range (ATR)
- ADVM 0.20
- GCTS 0.09
- MACD
- ADVM -0.03
- GCTS -0.01
- Stochastic Oscillator
- ADVM 51.58
- GCTS 19.32
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.